Hopp til hovedinnhold

Meningeom

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Goldbrunner R, Minniti G, Preusser M, Jenkinson MD, Sallabanda K, Houdart E, von Deimling A, Stavrinou P, Lefranc F, Lund-Johansen M, Moyal EC, Brandsma D, Henriksson R, Soffietti R, Weller M. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016 Sep;17(9):e383-91 . pmid:27599143 PubMed  
  2. Islim AI, Mohan M, Moon RDC, Rathi N, Kolamunnage-Dona R, Crofton A, Haylock BJ, Mills SJ, Brodbelt AR, Jenkinson MD. Treatment Outcomes of Incidental Intracranial Meningiomas: Results from the IMPACT Cohort. World Neurosurg. 2020 Jun;138:e725-e735. PMID: 32200011. PubMed  
  3. Apra C, Peyre M, Kalamarides M. Current treatment options for meningioma. Expert Rev Neurother. 2018 Mar;18(3):241-249. PMID: 29338455 PubMed  
  4. Alruwaili AA, De Jesus O. Meningioma. 2020 Aug 14. In: StatPearls Internet. Treasure Island (FL): StatPearls Publishing; 2020 Jan–. PMID: 32809373. PubMed  
  5. Islim AI, Kolamunnage-Dona R, Mohan M, Moon RDC, Crofton A, Haylock BJ, Rathi N, Brodbelt AR, Mills SJ, Jenkinson MD. A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro Oncol. 2020 Feb 20;22(2):278-289. PMID: 31603516 PubMed  
  6. Delgado-López PD, Corrales-García EM. Role of adjuvant radiotherapy in atypical (WHO grade II) and anaplastic (WHO grade III) meningiomas: a systematic review. Clin Transl Oncol. 2020 Jul 10. PMID: 32651886. PubMed  
  7. Vranic A, Peyre M, Kalamarides M. New insights into meningioma: from genetics to trials. Curr Opin Oncol 2012; 24: 660-5. PMID: 22820412 PubMed  
  8. Nayak L, Iwamoto FM, Rudnick JD, Norden AD, Lee EQ, Drappatz J, Omuro A, Kaley TJ. Atypical and anaplastic meningiomas treated with bevacizumab.J Neurooncol. 2012; 109: 187-93. PMID: 22544653 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor Phd
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Atle Eidet Hansen, spesialist i nevrologi